Paris Saclay Cancer Cluster (PSCC)
Created in 2022
Up & running (A)
Existing signals show a regular activitySocial networks
8,722Activities
Entity types
Location
94800 Villejuif, France
Villejuif
France
Employees
Scale: 2-10
Estimated: 23
Engaged catalyst
51
0 0Added in Motherbase
2 years, 1 month ago
Value proposition
Accelerating Innovation Against Cancer
The Paris Saclay Cancer Cluster (PSCC) is building a world-class biocluster to position France as the leading hub for cancer innovation. Selected by the French authorities as part of the Healthcare Innovation 2030 plan, the PSCC is a non-profit French Foundation for Scientific Cooperation (FCS) with a dual global ambition:
✅ Change the outcome of millions of patients fighting cancer worldwide
✅ Position France and Europe at the forefront of the 1st pharmaceutical industry
A world-class ecosystem driving innovation
Founded by Gustave Roussy, Sanofi, Inserm, Paris-Saclay University, and the Polytechnic Institute of Paris, the PSCC has rapidly expanded, welcoming key partners such as Unicancer, Institut Curie, AP-HP, and Medicen. With industry sponsors including Sanofi, Servier, GSK, IPSEN, and Merck, we act as a catalyst to transform breakthrough discoveries into industrial diagnostic and therapeutic solutions.
To accelerate this transformation, the PSCC provides a thriving environment including:
🔹 A premier location at Campus Grand Parc, Europe's leading cancer innovation hub, offering office/lab spaces with optimal solutions and controlled investment
🔹 Project support, access to mentors, funding, and strategic networks
🔹 Real-world data, biological samples, advanced technological & clinical platforms
🔹 A dynamic network bringing together Researchers, clinicians, startups, biotechs, pharma leaders, CROs, investors, public authorities and patients
Key Achievements & Impact
📌 150+ members within PSCC Connect
📌 50+ support companies (CROs, CDMOs, equipment providers, IP experts, etc.)
📌 Implementation at Campus Grand Parc
📌 5 academic platforms funded
📌 Major DATA initiative
📌 60 + projects supported to date, including:
-> €118M raised by 13 startups
-> 2 startups successfully acquired
🚀 Whether you're a startup, biotech, pharma company, CRO, or investor, join us and accelerate the next generation of cancer innovations!
oncologie, Cancer, Innovation, and OncoclusterOriginal language
Accelerating Innovation Against Cancer
The Paris Saclay Cancer Cluster (PSCC) is building a world-class biocluster to position France as the leading hub for cancer innovation. Selected by the French authorities as part of the Healthcare Innovation 2030 plan, the PSCC is a non-profit French Foundation for Scientific Cooperation (FCS) with a dual global ambition:
✅ Change the outcome of millions of patients fighting cancer worldwide
✅ Position France and Europe at the forefront of the 1st pharmaceutical industry
A world-class ecosystem driving innovation
Founded by Gustave Roussy, Sanofi, Inserm, Paris-Saclay University, and the Polytechnic Institute of Paris, the PSCC has rapidly expanded, welcoming key partners such as Unicancer, Institut Curie, AP-HP, and Medicen. With industry sponsors including Sanofi, Servier, GSK, IPSEN, and Merck, we act as a catalyst to transform breakthrough discoveries into industrial diagnostic and therapeutic solutions.
To accelerate this transformation, the PSCC provides a thriving environment including:
🔹 A premier location at Campus Grand Parc, Europe's leading cancer innovation hub, offering office/lab spaces with optimal solutions and controlled investment
🔹 Project support, access to mentors, funding, and strategic networks
🔹 Real-world data, biological samples, advanced technological & clinical platforms
🔹 A dynamic network bringing together Researchers, clinicians, startups, biotechs, pharma leaders, CROs, investors, public authorities and patients
Key Achievements & Impact
📌 150+ members within PSCC Connect
📌 50+ support companies (CROs, CDMOs, equipment providers, IP experts, etc.)
📌 Implementation at Campus Grand Parc
📌 5 academic platforms funded
📌 Major DATA initiative
📌 60 + projects supported to date, including:
-> €118M raised by 13 startups
-> 2 startups successfully acquired
🚀 Whether you're a startup, biotech, pharma company, CRO, or investor, join us and accelerate the next generation of cancer innovations!
Paris Saclay Cancer Cluster | Accélérer l’innovation en oncologie, accompagnement de startups Biotech & plus
Découvrez le Paris Saclay Cancer Cluster, un écosystème dédié à l’innovation en oncologie pour accélérer les découvertes. Accompagnement de startups biotech dans la recherche contre le cancer.
https://www.parissaclaycancercluster.org/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Le Réseau des Carnot | Other 9 Apr 2025 | | |
 | Carnot Curie Cancer | Other 16 Apr 2025 | | |
 | Institut Carnot CALYM | Other 11 Apr 2025 | | |
 CIC Bank, Banking | CIC Bank, Banking | Other 14 Mar 2025 | | |
 PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 14 Mar 2025 | | |
 Agoranov Startup accelerator & VC, Technology, Information and Internet | Agoranov Startup accelerator & VC, Technology, Information and Internet | Other 14 Mar 2025 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 14 Mar 2025 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Apr 2025 | | |
 BNP Paribas Bank, Banking | BNP Paribas Bank, Banking | Other 14 Mar 2025 | | |
 Quest for health Startup accelerator & VC | Quest for health Startup accelerator & VC | Other 22 Oct 2024 | | |